Semi-Annual Consolidated Statement Of Cash Flows

EnBio Holdings,Inc - Filing #7295171

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-183,251,000 JPY
1,370,149,000 JPY
Interest and dividends received
5,299,000 JPY
17,490,000 JPY
Interest paid
-64,710,000 JPY
-57,094,000 JPY
Net cash provided by (used in) operating activities
-258,855,000 JPY
1,022,064,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-732,425,000 JPY
-679,755,000 JPY
Purchase of investment securities
-3,265,000 JPY
-935,000 JPY
Loan advances
-141,255,000 JPY
-73,585,000 JPY
Other, net
-126,000 JPY
-28,884,000 JPY
Net cash provided by (used in) investing activities
-877,957,000 JPY
-789,128,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
922,005,000 JPY
921,985,000 JPY
Redemption of bonds
JPY
-18,500,000 JPY
Repayments of long-term borrowings
-1,149,765,000 JPY
-2,038,332,000 JPY
Proceeds from issuance of shares
JPY
1,056,000,000 JPY
Purchase of treasury shares
-34,987,000 JPY
JPY
Dividends paid
-64,909,000 JPY
-52,914,000 JPY
Net cash provided by (used in) financing activities
948,873,000 JPY
337,487,000 JPY
Purchase of shares of subsidiaries not resulting in change in scope of consolidation
JPY
-1,500,000 JPY
Effect of exchange rate change on cash and cash equivalents
11,461,000 JPY
-96,979,000 JPY
Net increase (decrease) in cash and cash equivalents
-176,477,000 JPY
473,443,000 JPY
Cash and cash equivalents
3,397,586,000 JPY
3,574,064,000 JPY
3,321,029,000 JPY
2,798,635,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.